Neurogene Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2014 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: Neurogene Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2014 to Q3 2024.
Neurogene Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $2.47M, a 541% increase year-over-year.
Neurogene Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $6.19M.
Neurogene Inc. annual Share-based Payment Arrangement, Expense for 2023 was $1.42M, a 13.3% increase from 2022.
Neurogene Inc. annual Share-based Payment Arrangement, Expense for 2022 was $1.25M, a 89.2% decline from 2021.
Neurogene Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.6M, a 106% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Quarterly (USD)

Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$6.19M	$2.47M	+$2.09M	+541%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-18
Q2 2024	$4.1M	$2.31M	+$1.93M	+503%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-09
Q1 2024	$2.17M	$1.05M	+$752K	+257%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-10
Q4 2023	$1.42M	$355K	+$5.89M		Oct 1, 2023	Dec 31, 2023	10-K	2024-03-18
Q3 2023	-$4.47M	$386K	-$1.65M	-81%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-18
Q2 2023	-$2.83M	$384K	-$1.93M	-83.4%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-09
Q1 2023	-$901K	$293K	-$2.15M	-88%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-10
Q4 2022	$1.25M	-$5.54M	-$8.55M	-284%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-18
Q3 2022	$9.8M	$2.03M	-$1.18M	-36.7%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	$11M	$2.31M	-$606K	-20.8%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-10
Q1 2022	$11.6M	$2.45M	+$26K	+1.07%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-08
Q4 2021	$11.6M	$3.01M	+$780K	+35%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-20
Q3 2021	$10.8M	$3.21M	+$1.52M	+90.2%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	$9.26M	$2.92M	+$1.9M	+186%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-09
Q1 2021	$7.36M	$2.42M	+$1.74M	+254%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-09
Q4 2020	$5.62M	$2.23M	+$1.59M	+246%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-01
Q3 2020	$4.04M	$1.69M	-$3.46M	-67.2%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	$7.5M	$1.02M	+$234K	+29.7%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-05
Q1 2020	$7.27M	$683K	-$417K	-37.9%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-12
Q4 2019	$7.68M	$644K	+$244K	+61%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-25
Q3 2019	$7.44M	$5.15M	+$3.65M	+243%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	$3.79M	$788K	-$712K	-47.5%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-12
Q1 2019	$4.5M	$1.1M	-$200K	-15.4%	Jan 1, 2019	Mar 31, 2019	10-Q	2019-05-07
Q4 2018	$4.7M	$400K	-$500K	-55.6%	Oct 1, 2018	Dec 31, 2018	10-K	2019-03-07
Q3 2018	$5.2M	$1.5M	+$300K	+25%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-13
Q2 2018	$4.9M	$1.5M	+$400K	+36.4%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-01
Q1 2018	$4.5M	$1.3M	+$700K	+117%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-07
Q4 2017	$3.8M	$900K	+$333K	+58.7%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-07
Q3 2017	$3.47M	$1.2M	+$700K	+140%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-07
Q2 2017	$2.77M	$1.1M	+$600K	+120%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-08
Q1 2017	$2.17M	$600K	+$167K	+38.6%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-08
Q4 2016	$2M	$567K	+$212K	+59.7%	Oct 1, 2016	Dec 31, 2016	10-K	2019-03-07
Q3 2016	$1.79M	$500K	+$76K	+17.9%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-08
Q2 2016	$1.71M	$500K	+$45K	+9.89%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-08
Q1 2016	$1.67M	$433K	+$167K	+62.8%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-09
Q4 2015	$1.5M	$355K	+$87K	+32.5%	Oct 1, 2015	Dec 31, 2015	10-K	2018-03-12
Q3 2015	$1.41M	$424K	+$191K	+82%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	$1.22M	$455K	+$240K	+112%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-04
Q1 2015	$982K	$266K	+$128K	+92.8%	Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-10
Q4 2014	$854K	$268K			Oct 1, 2014	Dec 31, 2014	10-K	2017-03-09
Q3 2014		$233K			Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-10
Q2 2014		$215K			Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-06
Q1 2014		$138K			Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-12

* An asterisk sign (*) next to the value indicates that the value is likely invalid.